Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Conditions

• Adult Favorable Prognosis Hodgkin Lymphoma
• Adult Lymphocyte Depletion Hodgkin Lymphoma
• Adult Lymphocyte Predominant Hodgkin Lymphoma
• Adult Mixed Cellularity Hodgkin Lymphoma
• Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
• Adult Nodular Sclerosis Hodgkin Lymphoma
• Adult Unfavorable Prognosis Hodgkin Lymphoma
• Recurrent Adult Hodgkin Lymphoma

Interventions

• DRUG: vorinostat
• OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)